-
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
28 May 2024 13:19 GMT
… and cytarabine) or FAI (fludarabine, cytarabine and idarubicin). The trial enrolled 388 … is developing the drug candidate for the treatment of severe … uses datapoints from individual drugs, clinical trials, regulatory milestones, company, …
-
Acute Myeloid Leukemia Market Forecast 2032: FDA Approvals, Clinical Trials, Epidemiology and Companies by DelveInsight
24 May 2024 17:22 GMT
… leukemia treatment include Fosciclopirox + Cytarabine, CPX … FDA-approved drugs for acute myeloid leukemia @ Acute Myeloid Leukemia clinical trials … for effective treatments. Pharmaceutical companies were … precision medicine and personalized treatment approaches …
-
Real-World Evidence of Relapsed/Refractory Mantle Cell Lymphoma Patients and Treatments: A Systematic Review
24 May 2024 18:52 GMT
… are usually based on clinical trial data.1 Nevertheless, it … for inclusion. Conversely, clinical trials, case studies, or case … bendamustine, and cytarabine (R-BAC).9,13 These treatment regimens included … raised interest in the medical community due to the …
-
The Role of Pharmacogenomics in Reducing Racial Disparities in Pediatric AML Treatment Outcomes
20 May 2024 23:48 GMT
… drug response and exploring new approaches to tailor treatments … aims to develop personalized medications based on an individual… in either trial.
Patients in the AML02 trial were … -dose cytarabine–based induction therapy in cooperative group trials,” the …
-
Risk adjusted net present value: What is the current valuation of Jazz Pharmaceuticals’s JZP-815?
16 May 2024 01:42 GMT
… opportunity in that drug, otherwise known … development for the treatment of solid … Pharmaceuticals is a specialty biopharmaceutical company which identifies, develops, and commercializes medicines … Vyxeos (daunorubicin and cytarabine) liposome for injection, …
-
A Strong Buy - Actinium Pharmaceuticals Promising AML Treatment With Targeted Radiotherapies
12 May 2024 14:20 GMT
… biotech risks. AML Solution: Business Overview Actinium Pharmaceuticals … its clinical trials, making it … treatment combined with chemotherapy regimens such as cladribine, cytarabine … trial supports a marketing authorization application to the European Medicines …
-
Uproleselan’s failed Phase III AML trial shakes up GlycoMimetics’ future
08 May 2024 13:15 GMT
… chemotherapy regimen — mitoxantrone, etoposide and cytarabine (MEC), or fludarabine, idarubicin, … , disease status and prior treatment exposure, may reveal a … remains slim as the biotech is running short of … face an under-addressed medical need and will lack …
-
GlycoMimetics reports data from Phase III AML treatment trial
07 May 2024 10:59 GMT
US-based biotechnology company GlycoMimetics has … its Phase III clinical trial of uproleselan, an E … mitoxantrone, etoposide and cytarabine (MEC) or fludarabine, cytarabine and idarubicin (FAI … for presentation at an upcoming medical meeting.”
Earlier this year …
-
Novel vaccine approach targets AML and other blood cancers
04 May 2024 06:23 GMT
… Pritzker Molecular Engineering doctoral candidate Anna Slezak, … University of Chicago Medicine Comprehensive Cancer Center, … adjuvant, usually a drug or chemical substance, … the researchers combined vaccine delivery with cytarabine treatment, a chemotherapy …
-
FDA Grants Breakthrough Therapy Status to Ziftomenib in R/R NPM1+ AML
24 Apr 2024 22:41 GMT
… Venclexta)/azacitidine or cytarabine/daunorubicin for patients … 1 KOMET-007 trial (NCT05735184). Treatment with ziftomenib plus … potential as an innovative medicine for patients with relapsed… working more closely with FDA to bring our ziftomenib …